1


Report to the
GAVI Alliance Board

Board -2012 -Mtg -2-Doc B
12 -13 June 2012
Subject : Programme update: country programmes
Report of: Paul Kelly, Director, Country Support , and
Bakhuti Shengelia, Director, Technical Coordination
Authored by: Paul Kelly and Bakhuti Shengelia
Agenda item : B
Category: For Information
Strategic goal : SG1, SG2, SG3


Section A: Overview

1. Purpose of the repor t

1.1 To update on implementation of GAVI country programmes since reporting to
the Board in November 2011.

2. Recommendations

2.1 This report is for information.

3. Executive summary

3.1 Good progress is being made in India and Nigeria. Pentavalent vaccine has
now been introduced in two states in December 2011 in India and in January
2012 GAVI received a request to scale -up to an additional six states. Nigeria?s
National Vaccine Summit in April has focused high level atte ntion on the
phase -in of pentavalent and pneumococcal vaccines. This will be supported
by reprogramming of GAVI HSS and ISS funds (up to $ 60m in total ) and
targeting of potential new funding (to the tune of US$ 40 million) until the
country graduates .

3.2 Alliance partners are working closely with DRC, Ethiopia and Pakistan to
support them to manage significant implementation challenges related t o
introducing and sustaining new vaccine s. DRC paid its 2010 co -financing
arrears in May 2012 and intends to pay the 2011 amount by June 201 2.

3.3 In February 2012, WHO, UNICEF and the Secretariat reviewed progress on
development of Alliance action plans to support countries achieve and
maintain DTP3 coverage above 70%. WHO will prioritise work in Chad , DRC
and Uganda and finalise plans in Q3 of 2012 .

GAVI Alliance Board Meeting
12-13 June 2012
Board-2012-Mtg-2 1


GAVI Alliance Board Meeting
12-13 June 2012
Washington, DC, USA

FINAL MINUTES

1. Chair?s report and consent agenda

Chair?s report
1.1 Finding a quorum of members present, the meetin g commenced at 9.02
Washington time on 12 June 2011. Dagfinn H?ybr?ten, Board Chair, chaired
the meeting.

1.2 The Chair opened the meeting by referencing the Norwegian concept of a
?dugnad,? which he explained was a group of people who come together to
solve problems for the common good. He observed tha t this Board was a
dugnad, and encouraged Board members to engage with each other in that
spirit.
1.3 The Chair referenced the Child Survival Call to Action organised by USAID,
UNICEF, and the governments of India and Ethiopia t o be held at Georgetown
University on 14-15 June 2012. He also announced th e publication of the
GAVI 2011 progress report, noting that a special on line edition was available.
He reminded the Board that 2011 had been a successf ul year: routine
immunisation rates reached 80%, the Board hired a n ew CEO, and GAVI met
its funding challenge. Now the Chair declared GAVI must ?deliver, deliver,
deliver? on the promises made at the pledging confe rence in June 2011.

1.4 Standing declarations of interest were tabled t o the Board (Doc 1a in the
Board pack). Alan Hinman noted that the Novartis re search grant reported in
Doc 1a was for rabies rather than measles. However, he declared an interest
in the measles decision since he leads a project th at works with the Measles-
Rubella Initiative (MR Initiative). He would recuse himself from that item. Anne
Schuchat reported that the US Centers for Disease C ontrol is involved with
some of the special studies to be discussed at this meeting and in the MR
Initiative; she would recuse herself from those mat ters. Nicholas Alipui and
Simon Bland declared they had no financial/personal interests in any of the
matters to be discussed at this meeting; so their o nly interests were in matters
involving UNICEF and DFID, respectively. Maria C. F reire declared interests
in any matters involving the Lasker Foundation (whe re she serves as
president) or Johns Hopkins University (where a fam ily member is employed),

Debbie Adams
Consent agenda
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Decision 1: Board and Committee member
appointments (1/4)
1
The GAVI Alliance Board :
? Appointed the following member to the Audit and Finance
Committee effective immediately and until the committees
are refreshed for the 2013 year :
? Yifei Li

Seth Berkley MD
CEO
CEO Board report


GAVI Alliance Board meeting
Washington DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Overview of presentation
? New results
? Accelerated activities
? Expenditure and resources ? horizon view
? Opportunities and challenges
? Board agenda: key decisions and themes for
discussion
1

Wayne Berson
Audit and Finance Committee
Chair Report
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Activity since November 2011 Board meeting
? 1 video/teleconference meeting
? Areas reviewed:
1. Financial reporting and audit
2. Financial forecast / programme approvals /
programme funding policy amendment
3. Report of the Internal Auditor
4. Currency hedging
5. Risk management
6. Legal matters



1

Barry Greene
Financial forecast
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Projected demand
1
Includes the new
vaccine windows
(MR, HPV, JE, typhoid)
Prior to any other
new vaccines (and
measles option)
Includes VIG policy
change - the main
difference since last
forecast





2011 -15 : $8.0 bn

2016 -20: $7.9 bn
Indicative

Cees Klumper
Report of the internal auditor
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Topics for discussion
1
? R isk management:
? The process
? Cash support
? Vaccine support
? Investigations update
? Priorities for the coming year

Barry Greene
Amendment to the
Programme Funding Policy
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012 ~
GAVI Alliance Board meeting
12 -13 June 2012
Background
? Opportunity to streamline processes
? ?Rolling? basis for HSFP proposals from 2012
? requires more frequent funding allotments
? Need for timely operational adjustments to
budgets ? between committee meetings
? Essential to maintain due governance
? while improving operational efficiency
1

Helen Evans
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
Business planning process and risk
management update
GAVI Alliance Board meeting
12 ?13 June 2012
Business Plan 2013 ? 1 4 process
1
June
Board
Define high level priorities
for 2013 ?14
Dec
Board
Adjust business plan
and budget
1 2
? Each institution proposes
deliverables, activities and
budgets
? Coordination and feedback
provided by the Secretariat
? Review by External Advisory
Group
? Review by PPC, AFC
? Board approval
? Review the experience over
the first 2 years
? Interviews with many Board
members
? Workshops with Board
constituencies for
? SG 1, 2 & 3
? M & E
TODAY:
Validate
strategic priorities
Approve
Business Plan

Debbie Adams
Amendments to Statutes
and By -Laws
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Decision 6: Amendments to Statutes and By -
Laws (1/3)
1
The GAVI Alliance Board :
? Amended By -Laws Article 3.1.1, clause 3 as follows:
? Up to eight additional Board Members (or Alternate
Board Members), who shall each be a voting member of
the Executive

Nina Schwalbe
Options for enhancing GAVI?s
investment in measles prevention
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Background and aim of increased GAVI
engagement
? Estimated measles mortality has plateaued around
140,000 deaths.
? Increased routine coverage critical to sustainably
controlling measles
? Outbreaks possible (e.g. every 3 ? 5 years) unless
coverage is high
? GAVI support:
? Long -term strategy for control in six countries
through high routine coverage
? outbreak prevention

Aur?lia Nguyen
Vaccine introduction grants and
operational support for campaigns
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Background: Vaccine introduction grants
1
? Until March 2012, GAVI had disbursed ~ 150 vaccine
introduction grants (US$ 28.6m total).

2001 2007 2011 ?12
US$ 100,000 lump
sum for all countries
Revised policy : US$ 100,000 or
US$ 0.30/child in birth cohort
Policy under review to better
serve newer vaccines
e.g. Kiribati Bangladesh
$ $
$
$

?
Newer vaccines: pneumococcal,
rotavirus, HPV , rubella
campaigns
e.g. Kiribati Bangladesh